We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4.02%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Adobe
ADBE
$84.3B
| $1.04B | 2.37% |
4,791,084
-577,712
| -11% | -$117M |
|
2
Home Depot
HD
$324B
| $929M | 2.13% |
5,213,718
+1,154,699
| +28% | +$217M |
|
|
3
Boeing
BA
$165B
| $917M | 2.1% |
2,796,515
+942,769
| +51% | +$319M |
|
4
Mastercard
MA
$469B
| $869M | 1.99% |
4,962,610
+945,252
| +24% | +$162M |
|
|
5
AbbVie
ABBV
$454B
| $778M | 1.78% |
8,216,564
+6,133,793
| +295% | +$674M |
|
6
Comcast
CMCSA
$78.3B
| $741M | 1.7% |
21,675,907
+4,601,378
| +27% | +$178M |
|
7
UnitedHealth
UNH
$385B
| $724M | 1.66% |
3,381,573
-941,607
| -22% | -$215M |
|
8
Canadian National Railway
CNI
$79.2B
| $711M | 1.63% |
9,727,940
+3,707,616
| +62% | +$286M |
|
9
Meta Platforms (Facebook)
META
$1.54T
| $646M | 1.48% |
4,044,831
-479,815
| -11% | -$86.2M |
|
10
Lockheed Martin
LMT
$131B
| $617M | 1.42% |
1,825,863
+533,910
| +41% | +$182M |
|
|
11
IBM
IBM
$195B
| $606M | 1.39% |
4,128,870
+2,693,837
| +188% | +$408M |
|
12
Vale
VALE
$63.1B
| $553M | 1.27% |
43,501,452
+13,770,746
| +46% | +$181M |
|
|
CELG
13
DELISTED
Celgene Corp
CELG
| $553M | 1.27% |
6,194,302
+3,278,894
| +112% | +$315M |
|
14
Applied Materials
AMAT
$447B
| $508M | 1.17% |
9,133,521
-1,987,511
| -18% | -$111M |
|
15
Intuitive Surgical
ISRG
$119B
| $462M | 1.06% |
3,354,123
+349,431
| +12% | +$48.8M |
|
16
Intuit
INTU
$77B
| $461M | 1.06% |
2,660,104
-735,473
| -22% | -$124M |
|
17
Salesforce
CRM
$129B
| $450M | 1.03% |
3,869,338
+300,466
| +8% | +$34.5M |
|
18
Berkshire Hathaway Class B
BRK.B
$1.06T
| $430M | 0.99% |
2,153,435
+538,154
| +33% | +$111M |
|
19
Walt Disney
DIS
$161B
| $417M | 0.96% |
4,154,186
-1,878,731
| -31% | -$200M |
|
20
Bristol-Myers Squibb
BMY
$126B
| $416M | 0.95% |
6,569,930
+75,710
| +1% | +$4.87M |
|
|
21
Toronto Dominion Bank
TD
$197B
| $412M | 0.95% |
7,257,828
+6,704,828
| +1,212% | +$392M |
|
22
CME Group
CME
$91.9B
| $405M | 0.93% |
2,506,345
+305,012
| +14% | +$48.6M |
|
23
Johnson & Johnson
JNJ
$624B
| $401M | 0.92% |
3,126,119
+2,267,727
| +264% | +$307M |
|
24
Automatic Data Processing
ADP
$97.1B
| $388M | 0.89% |
3,421,923
-571,471
| -14% | -$66.6M |
|
25
PepsiCo
PEP
$184B
| $378M | 0.87% |
3,464,975
+1,856,681
| +115% | +$211M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.